Treatment of Metastatic Colorectal Carcinoma with Bevacizumab in First-Line and beyond First Progression: The KORALLE Non-Interventional Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "Oncology Research and Treatment"
DOI: 10.1159/000525031
Abstract: Introduction: The non-interventional study (NIS) KORALLE evaluated the effectiveness and safety of bevacizumab in patients with metastatic colorectal carcinoma (mCRC) treated with bevacizumab in combination with fluoropyrimidine-based chemotherapy in the first-line setting and beyond first… read more here.
Keywords: first progression; first line; koralle; bevacizumab ... See more keywords